GlassScriptPhysician profile
Jamie L Verhoff
NPI 1578195376
$2,699.68
in general payments reported to CMS, 2019-2025
25 companies · $1,168 in 2025
The $1,168 reported for 2025 was more than what 87% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $172 · 2022: $157 · 2023: $510 · 2024: $692 · 2025: $1,168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,228 · Education: $142.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,228.28 |
| Education | $141.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $782.20 | 2021-2025 | Farxiga, Wainua, Andexxa |
| Abbott Laboratories | $381.49 | 2023-2025 | Cardiomems |
| Novo Nordisk INC | $365.29 | 2024-2025 | Wegovy, Rybelsus, Ozempic |
| Pfizer INC. | $179.05 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $123.76 | 2024-2025 | |
| Philips North America LLC | $98.68 | 2022-2023 | |
| Insulet Corporation | $92.46 | 2025 | Omnipod |
| Corcept Therapeutics | $86.50 | 2025 | Korlym |
| Xeris Pharmaceuticals, INC. | $83.00 | 2024-2025 | Recorlev, Gvoke Hypopen |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $65.71 | 2021-2024 | Lifevest |
| Mannkind Corporation | $59.46 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $46.35 | 2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $45.76 | 2021-2023 | |
| Boston Scientific Corporation | $38.44 | 2022-2023 | |
| Alnylam Pharmaceuticals INC. | $34.65 | 2025 | Onpattro |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $31.50 | 2025 | Zepbound, Mounjaro |
| Janssen Pharmaceuticals, INC | $29.64 | 2023 | Xarelto |
| Dexcom, INC. | $25.73 | 2025 | Dexcom G6 Transmitter |
| Cvrx, INC. | $24.25 | 2024 | Barostim Neo System |
| Vertex Pharmaceuticals Incorporated | $23.72 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $20.82 | 2025 | Eliquis |
| Bridgebio Pharma, INC. | $19.72 | 2025 | Attruby |
| Scpharmaceuticals INC. | $14.62 | 2024 | |
| Abiomed | $13.99 | 2025 | |
| Cequr Corporation | $12.89 | 2024 | Cequr Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Verhoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.